Polymorphonucleates activity in dialysis patients treated with different membranes
Nanni Costa, A.; Stefoni, S.; Feliciangeli, G.; Colì, L.; Buscaroli, A.; Mosconi, G.; Boni, P.; Iannelli, S.; Lucatello, A.; Bruni, L.
Life Support Systems the Journal of the European Society for Artificial Organs 3(Suppl 1): 23-27
1985
ISSN/ISBN: 0261-989X PMID: 3870569 Document Number: 252166
Document emailed within 1 workday
Related Documents
Jakić, M.; Stipanić, S.; Mihaljević, D.; Zibar, L.; Lovcić, V.; Klarić, D.; Jakić, M. 2005: The impact of glucose absorbed from dialysis solution on body weight gain in peritoneal dialysis treated patients Lijecnicki Vjesnik 127(5-6): 116-120Opatrná, S.; Racek, J.; Stehlík, P.; Senft, V.; Sefrna, F.; Topolcan, O.; Opatrný, K. 2002: Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis Casopis Lekaru Ceskych 141(9): 281-285
Sułowicz, W. 1990: Activity of some lysosomal enzymes in peritoneal macrophages of patients with end-stage renal failure treated by intermittent peritoneal dialysis Folia Haematologica 117(5): 663-667
Leuenberger, R.; Brunner, F.; Kummer, H.; Benninger, J.L.; Hodler, J. 1972: On the effect of alteration in the acidity of the dialysis solution on the survival time and the metabolism of the erythrocytes in patients with terminal renal insufficiency treated with long-term dialysis Schweizerische Medizinische Wochenschrift 102(1): 18-24
Chiappini, M.G.; Ammann, T.; Selvaggi, G.; Bravi, M.; Traietti, P. 2004: Effects of different dialysis membranes and techniques on the nutritional status, morbidity and mortality of hemodialysis patients Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 21(Suppl 30): S190-S196
Krawczyk, W.; Marczewski, K.; Ledwozyw, A. 1995: Level of the C3c complement in uremic patients hemodialyzed with three different dialyzer membranes, prior to the dialysis seance Clinical Nephrology 44(5): 340
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203
Zharfbin, A. 2006: Dyslipidemia in patients being treated with peritoneal dialysis Vnitrni Lekarstvi 52(11): 1051-1057
Martín Reyes, G.; Valera, A.; Frutos, M.A.; Ramos, B.; Ordóñez, V.; López de Novales, E. 2003: Survival of myeloma patients treated with dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 23(2): 131-136
Vanĕcek, V.; Kotrlík, J. 1980: Gastrointestinal hemorrhage in patients regularly treated with dialysis Vnitrni Lekarstvi 26(10): 963-968
Korten, G. 1988: Nutritional problems in patients treated with chronic dialysis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 43(7): 183-187
Kaiser, G.; Gál, G.; Mészáros, E. 1975: Transfusion-immunization in uremic patients treated by chronic dialysis Orvosi Hetilap 116(11): 604-607
Poirier, J.M.; Joannides, R.; Geffroy-Josse, S.; Fillastre, J.P.; Etienne, I. 1992: Propafenone pharmacokinetics in uremic patients treated by peritoneal dialysis Clinical Nephrology 38(4): 231-232
Bistrup, C.; Siboni, A.H.; Pedersen, R.S. 1995: Peritonitis among patients treated with continuous ambulatory peritoneal dialysis Ugeskrift for Laeger 157(28): 4023-4026
López Uriarte, A.; Cuan Pérez, M.; Torres Zamora, M. 1972: Hemopericardium in patients with chronic renal insufficiency treated by peritoneal dialysis Archivos del Instituto de Cardiologia de Mexico 42(5): 745-753
Harwell, C.M.; Newman, L.N.; Cacho, C.P.; Mulligan, D.C.; Schulak, J.A.; Friedlander, M.A. 1997: Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(6): 586-594
Sulková, S.; Schönová, S. 1988: Should arterial hypertension in patients on regular dialysis therapy be treated with hypotensive agents? Casopis Lekaru Ceskych 127(15): 453-455
Adeniyi, M.; Kassam, H.; Agaba, E.I.; Sun, Y.; Servilla, K.S.; Raj, D.S.C.; Murata, G.H.; Tzamaloukas, A.H. 2009: Hospitalizations in patients treated sequentially by chronic hemodialysis and continuous peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 25: 72-75
Martínez, M.E.; Miguel, J.L.; Gómez, P.; Selgas, R.; Salinas, M.; Gentil, M.; Mateos, F.; Montero, J.L.; Sánchez Sicilia, L. 1983: Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD Clinical Nephrology 19(5): 250-253
Maher, J.F. 1993: Cardiovascular disease and risk factors in patients treated by continuous ambulatory peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S383-S393